Accelerate Diagnostics, Inc.
AXDX Real Time Price USDRecent trades of AXDX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AXDX's directors and management
Government lobbying spending instances
-
$10,000 Nov 06, 2017 Issue: Medical/Disease Research/Clinical Labs Science/Technology
-
$10,000 Jul 17, 2017 Issue: Science/Technology
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing Mar. 26, 2024
-
Patent Title: Rapid determination of microbial growth and antimicrobial susceptibility Mar. 14, 2023
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Aug. 10, 2021
-
Patent Title: Lens-free holographic optical system for high sensitivity label-free microbial growth detection and quantification for screening, identification, and susceptibility testing Aug. 03, 2021
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Jul. 06, 2021
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Apr. 30, 2019
-
Patent Title: Membrane-assisted purification Apr. 09, 2019
-
Patent Title: Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing Apr. 09, 2019
-
Patent Title: Rapid cell purification systems Feb. 12, 2019
-
Patent Title: Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing Jul. 17, 2018
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Dec. 12, 2017
-
Patent Title: Cartridge Oct. 03, 2017
-
Patent Title: Rapid cell purification systems Jul. 25, 2017
-
Patent Title: Rapid determination of microbial growth and antimicrobial susceptibility Jun. 13, 2017
-
Patent Title: Rapid microbial detection and antimicrobial susceptibility testing May. 23, 2017
-
Patent Title: Cartridge Dec. 06, 2016
-
Patent Title: Cassette Dec. 06, 2016
-
Patent Title: Rapid cell purification systems Sep. 06, 2016
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Nov. 25, 2014
-
Patent Title: Sensitive and rapid determination of antimicrobial susceptibility Jun. 11, 2013
Federal grants, loans, and purchases
- $110,100 2024-04-24 00:00:00 Agency: Department of Veterans Affairs
- $57,585 2024-04-19 00:00:00 Agency: Department of Veterans Affairs
- $57,189 2023-11-17 00:00:00 Agency: Department of Veterans Affairs
- $110,100 2023-06-08 00:00:00 Agency: Department of Veterans Affairs
- $57,386 2023-05-17 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-05-03 00:00:00 Agency: Department of Veterans Affairs
- $110,100 2022-06-03 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $134,385 2022-01-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,900 2021-10-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $55,276 2021-08-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $166,200 2021-08-12 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $110,100 2021-06-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $11,700 2020-10-01 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of AXDX in WallStreetBets Daily Discussion
Recent insights relating to AXDX
Recent picks made for AXDX stock on CNBC
ETFs with the largest estimated holdings in AXDX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AXDX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.